About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

International paediatric bronchiectasis registry (Child-BEAR-Net registry)

Dear Colleagues,

Bronchiectasis in children remains an understudied syndrome, with insufficient comprehensive information on its epidemiology, aetiology, comorbidities, pathophysiology, and prognosis. In childhood, bronchiectasis is defined as a clinical syndrome characterized by a chronic wet cough, recurrent respiratory exacerbations, and abnormal bronchial dilatation observed on high-resolution chest computed tomography. Bronchiectasis represents a common outcome of various aetiologies, all characterised by inflammation, impaired mucus clearance, and chronic bacterial infection.

To address the neglected field of bronchiectasis in children, the Clinical Research Collaboration known as the Childrenโ€™s Bronchiectasis Education, Advocacy, and Research Network (Child-BEAR-Net), funded by the European Respiratory Society, has built an international paediatric bronchiectasis registry (Child-BEAR-Net Registry). The aims of the Child-BEAR-Net Registry are:

  • Collect longitudinal information on clinical characteristics, epidemiology, aetiology, comorbidities and management
  • Conduct annual longitudinal follow-up
  • Create a framework for future consensus, interventions, collaborations and research projects both, at both the international level and with the European Bronchiectasis Registry (EMBARC)

We invite all centers within the ERN-Lung network that treat paediatric patients (aged 0 to 17 years) diagnosed with bronchiectasis (excluding cystic fibrosis) to participate in this project.

Your participation in the Child-BEAR-Net registry will contribute to advancing the understanding of bronchiectasis features in children by describing this population and identifying any distinct characteristics between different countries and regions. Additionally, it will provide valuable information on prevalence and incidence, expand the knowledge of its natural history, improve management and treatment strategies, and ultimately enhance the quality of life for paediatric patients with bronchiectasis.

Child-BEAR-Net offers the possibility to establish national registries, with data subsequently transferred to the international registry.

For more information, please contact: childbearnet@qut.edu.au
Sincerely,

Child-BEAR-Net Committee